GlassScriptPhysician profile
David S Hamer
NPI 1336176429
$7,052.95
in general payments reported to CMS, 2019-2025
33 companies · $525 in 2025
The $525 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,158 · 2020: $1,269 · 2021: $803 · 2022: $999 · 2023: $757 · 2024: $541 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,823.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,647.78 | 2019-2025 | Mylux Patient Kit With Mobile Device, Latitude Communicator Power Supply, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,141.05 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $1,052.27 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $497.66 | 2019-2023 | Xarelto |
| Abbott Laboratories | $490.89 | 2020-2024 | Cardiomems, Xience Skypoint |
| Novartis Pharmaceuticals Corporation | $319.88 | 2019-2023 | |
| Medtronic, INC. | $282.27 | 2022-2025 | Corevalve Evolut R |
| Tactile Systems Technology INC | $199.52 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Impulse Dynamics (USA) INC. | $179.14 | 2022-2023 | Optimizer |
| Amarin Pharma, INC. | $141.95 | 2019-2021 | |
| Amgen INC. | $115.56 | 2019-2025 | Repatha |
| Pfizer INC. | $106.61 | 2019-2024 | |
| Viiv Healthcare Company | $89.23 | 2019-2020 | |
| Gilead Sciences, INC. | $86.76 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $85.39 | 2019-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $84.02 | 2019-2022 | |
| Abbvie INC. | $73.42 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.43 | 2019-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $55.92 | 2025 | Assure Wcd |
| Zoll Circulation INC | $51.50 | 2020 | |
| Angiodynamics, INC. | $48.56 | 2024 | Alphavac |
| Glaxosmithkline, LLC. | $46.65 | 2019-2021 | |
| Itamar Medical INC | $24.26 | 2024 | Watchpatone |
| Astellas Pharma US INC | $23.29 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.25 | 2022 | |
| Cardiva Medical, INC. | $21.45 | 2022 | |
| Elutia, INC. | $17.04 | 2020 | |
| Janssen Biotech, INC. | $16.51 | 2019 | |
| Abiomed | $14.42 | 2020 | |
| Shionogi INC | $14.39 | 2021 | |
| Emd Serono, INC. | $12.98 | 2019 | |
| Vyera Pharmaceuticals, LLC | $12.73 | 2020 | |
| Melinta Therapeutics, LLC | $11.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hamer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.